News

Actoverco Pharmaceutical Company

Selected News

لانچ داروی دیابت اکتوورکو (1)

The combined diabetes medicine was produced by Iranian scientists!

actover news-min

Actoverco launches diabetes drug “Trytis”

labour day

“International Labour Day”

فوتسال-min

Actoverco host a Futsal tournament!

nahaleh naraqi owner of actoverco

Bright future for pharmaceutical industry in Iran!

Eid al-Fitr: A Celebration of Faith, Renewal, and Prosperity

Eid al-Fitr, a celebration of devotion and righteousness, marks the dawn of divine mercy and the season of harvesting the vibrant fruits of answered prayers. Wishing all Muslims around the world a blessed Eid.

First AcTrip Conference Held to Address Hypothyroidism Screening, Diagnosis, and Treatment

The first session of the AcTrip (Actoverco Thyroid Insight Practice) conference series, organized by Actoverco Pharmaceutical Group, was held with the aim of reviewing the challenges of screening, diagnosis, treatment, and follow-up of hypothyroidism (underactive thyroid). The event brought together 300 distinguished physicians and leading endocrinologists.

Atipharmed Supports the 6th International Congress on Minimally Invasive Techniques in Gynecology and Endometriosis

The 6th International Congress on Minimally Invasive Techniques in Gynecology, Obstetrics, and Endometriosis took place from January 23 to 25 at Abureihan Hall, Shahid Beheshti University, with Atipharmed, a subsidiary of Actoverco, as its key sponsor.

Scientific Conference on the Effects of Hormone Replacement Therapy (HRT) in Menopause

The scientific seminar on the effects of hormone replacement therapy (HRT) during menopause, introducing Gynati and Prequin drugs by Ati Pharmed Pharmaceutical Company, was held.

Holding the 21st MS Congress of Iran with the participation of Actoverco

The 21st MS Congress of Iran was held from December 4th to 6th, 2024, and organized by the Multiple Sclerosis Research Center of Tehran University of Medical Sciences at the International Conference Hall of the Olympic Hotel.

Presentation of Actover’s latest products at the Gastrointestinal and Liver Diseases Congress

The 24th Congress of Gastrointestinal and Liver Diseases was held with the support of Actover Pharmaceutical Group.

Introduction of Actoverco Cardiovascular Medications at the 8th International Heart Failure Congress

The 8th International Heart Failure Congress of Iran was held from December 7th to 9th, supported by the Actover pharmaceutical group, at the International Conference Center of Shahid Beheshti University.

Actoverco’s Contribution to the 40th Annual Congress of the Iranian Psychiatric Association

The 40th Annual Congress and the 23rd consecutive gathering of the Iranian Psychiatric Association took place from October 7 to 10 at Milad Hospital in Tehran, with active participation by ActoverCo.

Introduction of Two Progesterone Drugs by Ati Pharmed at the Royan International Congress

Ati Pharmed Company introduced two of its products, Actogest and Dofamed, during a scientific symposium held at the 25th International Congress on Reproductive Medicine, the 20th Congress on Stem Cell Technology, and the 19th Midwifery Nursing Seminar at Royan Institute.

Nahale Naraghi honors Pharmacist Day with a special message!

Nahaleh Naraqi honors Pharmacist Day with a special message!

Nahale Naraghi honors Pharmacist Day with a special message of gratitude, recognizing the essential role pharmacists play in advancing healthcare and supporting patient well-being

Nahaleh naraqi

Nahaleh Naraqi’s congratulatory message on the occasion of Doctor’s Day

Nahale Naraghi honors National Doctors Day in Iran, coinciding with Avicenna’s birthday.

Treatment and Reduction of Menopause Symptoms with New Drugs by “Atipharmed”

The pharmaceutical company “Atipharmed,” a subsidiary of the Actover Group, has introduced two new drugs to the national market, which are used for hormone therapy and alleviating post-menopause symptoms and issues.